Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.70    0.00 (0.00%)
Bid:
3.40
Ask:
4.00
Spread: 0.60 (17.647%)
Market Cap: £4.61m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Half-year Report

18 Aug 2023 15:12

RNS Number : 8240J
Primorus Investments PLC
18 August 2023
Β 

Primorus Investments plc

Β 

("Primorus" or the "Company")

Β 

Interim Results for the six months ended 30 June 2023

Β 

Primorus Investments plc (AIM: PRIM) is pleased to announce its unaudited interim results for the six months ended 30 June 2023.

Β 

Overview

Β 

The last six months have been a difficult time for the capital markets with rising interest rates causing a general slowdown in the deployment of capital being invested. With greater uncertainties, investors are more cautious which has had a negative effect on the asset valuations for some of Primorus' investments. Despite this, we remain confident in the longer-term prospects of these investments.

Β 

Primorus has restructured the repayments due under its Convertible Loan Note with Bushveld Minerals Limited. At the date of this announcement, Β£307,000 has been repaid and the balance continues to accrue interest at 10% per annum.

Β 

Alteration Earth PLC, a special purpose acquisition company in which Primorus holds approximately 28% of the issued share capital, announced on 1 August 2023 its intention to acquire the entire issued share capital of Verdant Earth Resources Limited.

Β 

In addition, Primorus has exited several non-core holdings to ensure the Company remains in a healthy position to deliver the objectives set out within its investing policy.

Β 

Financial Results

Β 

The operating loss for the six months to 30 June 2023 was Β£512,000 (30 June 2022: Β£847,00 loss). The net loss after tax was Β£512,000 (30 June 2022: Β£847,000 loss).

Β 

Total assets, including cash, at 30 June 2023 amounted to Β£7.21 million (30 June 2022: Β£8.23 million).

Β 

Outlook

Β 

The Board remains confident that significant opportunities exist for the Company going forward. The Board is continually seeking new investment opportunities whilst also monitoring its existing investments.

Β 

The Board has screened several exciting opportunities within the period and looks forward to making further investments in the near term.

Β 

We look forward to updating shareholders as and when our existing investments mature, and new investments present themselves.

Β 

The Directors would like to take this opportunity to thank our shareholders and consultants for their continued support.

Β 

Rupert Labrum Chairman

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Β 

Β 

Caution regarding forward looking statements

Β 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identied by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting the Company will be those that it anticipates.

Β 

Β 

For further information please contact:

Β 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

Β 

+44 (0)20 8154 7907

Β 

Nominated Adviser

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

Β 

+44 (0) 20 7213 0880

Β 

Β 

Β 

Β 

Unaudited Condensed Company Statement of Comprehensive Income

for the six months ended 30 June 2023

Β 

6 months to

6 months to

Year to

30 June

2023

30 June

2022

31 December

2022

Unaudited

Unaudited

Audited

Notes

Β£'000

Β£'000

Β£'000

Continuing operations

Revenue

Investment income

40

52

93

Realised (loss)/gain on disposal of financial investments

(538)

(300)

(288)

Unrealised gain/(loss) on market value movement of financial investments

314

(500)

(542)

Total (losses)/gains on financial investments

(184)

(748)

(737)

Share based payments

-

(63)

(121)

Operating costs

(328)

(36)

(280)

Β 

Impairment of financial investments

Β 

-

Β 

-

Β 

(375)

(Loss)/Profit before tax

(512)

(99)

(1,513)

Taxation

-

-

29

(Loss)/Profit for the period attributable to equity shareholders of the company

(512)

(847)

(1,484)

Β 

Other comprehensive income

-

-

-

Total Comprehensive Income for the year attributable to equity shareholders of the company

Β 

(512)

Β 

(847)

Β 

(1,484)

Β 

Profit/(Loss) per share:

Basic profit/(loss) per share (pence)

2

(0.366)

(0.605)

(1.061)

Diluted profit/(loss) per share (pence)

2

(0.366)

(0.605)

(1.061)

Β 

Β 

Unaudited Condensed Company Statement of Financial Position

as at 30 June 2023

Β 

30 June

2023

30 June

2022

31 December

2022

Unaudited

Unaudited

Audited

Note s

Β£'000

Β£'000

Β£'000

ASSETS

Non-current assets

Financial investments

5,279

7,742

5,444

5,279

7,742

5,444

Β 

Current assets

Investments

1,843

20

2,064

Trade and other receivables

49

39

34

Cash and cash equivalents

35

427

114

1,927

486

2,212

Total assets

7,206

8,228

7,656

Β 

EQUITY

Equity attributable to equity holders of the parent

Share capital

280

280

280

Share based payment reserve

-

76

-

Retained earnings

6,754

7,769

7.266

Total equity

7,034

8,125

7.546

LIABILITIES

Current liabilities

Trade and other payables

172

70

110

Corporation tax

-

33

-

Total liabilities

172

103

110

Total equity and liabilities

7,206

8,228

7,656

Β 

Unaudited Condensed Company Statement of Changes in Equity

for the six months ended 30 June 2023

Β 

Β 

Share capital

Β 

Share premium

Share based

payment reserve

Β 

Retained earnings

Total attributable

to owners of parent

Β 

Β£'000

Β£'000

Β£'000

Β£'000

Β£'000

Unaudited

Β 

Β 

Β 

Β 

Β 

Balance at 31 December 2021

280

-

13

8,616

8,909

Β 

Loss for the period

Β 

-

Β 

-

Β 

-

Β 

(1,484)

Β 

(1,484)

Total comprehensive income for the

period

Β 

-

Β 

-

Β 

-

Β 

(1,484)

Β 

(1,484)

Share based payment expense

Β 

-

-

121

-

121

Reclassification upon cancellation of share options

Β 

-

-

(134)

134

-

Β 

Balance at 31 December 2022

Β 

280

Β 

-

Β 

-

Β 

7,266

Β 

7,546

Β 

Loss for the period

Β 

-

Β 

-

Β 

-

Β 

(512)

Β 

(512)

Total comprehensive income for the period

Β 

-

Β 

-

Β 

-

Β 

(512)

Β 

(512)

Balance at 30 June 2023

280

-

-

6,754

7,034

Β 

Β 

Β 

Unaudited Condensed Company Statement of Cash Flows

for the six months ended 30 June 2023

Β 

Β 

6 months to

6 months to

Year

to

30-Jun-23

30-Jun-22

31-Dec-22

Unaudited

Unaudited

Audited

Β£'000

Β£'000

Β£'000

Cash flows from operating activities

Operating Profit/(Loss)

(512)

(847)

(1,484)

Adjustments for:

(Profit)/Loss on disposal of financial investments

538

300

288

Fair value movement on listed investments

(314)

500

542

Impairment provision on unlisted investments

-

-

375

Decrease/(increase) in trade and other Β receivables

(15)

(34)

-

Increase/(decrease) in trade and other payables

62

26

66

Foreign exchange loss/(gain)

166

(132)

(112)

Interest income on investments

(40)

(52)

(93)

Share based payment

-

63

121

Income tax (credit)

-

-

(29)

Β 

(115)

(176)

(326)

Β 

Income taxes paid

Β 

-

Β 

(4)

Β 

(36)

Β 

Net cash used in operating activities

(115)

(180)

(362)

Cash flows from investing activities

Disposal proceed from sale of financial investments

Β 

36

Β 

3,026

Β 

1,937

Payment for financial investments

-

(3,360)

(2,402)

Net cash from/(used in) investing activities

36

(334)

(465)

Net change in cash and cash equivalents

(79)

(514)

(827)

Β 

Cash and cash equivalents at beginning of period

Β 

114

Β 

941

Β 

941

Cash and cash equivalents at end of period

35

427

114

Β 

Β 

Notes to the condensed unaudited interim financial statements

Β 

1. General Information

Β 

The condensed interim financial information for the 6 months to 30 June 2023 does not constitute statutory accounts for the purposes of Section 434 of the Companies Act 2006 and has not been audited or reviewed. No statutory accounts for the period have been delivered to the Registrar of Companies.

Β 

The condensed interim financial information in respect of the year ended 31 December 2022 has been produced using extracts from the statutory accounts for that period. Consequently, this does not constitute the statutory information (as defined in section 434 of the Companies Act 2006) for the year ended 31 December 2022, which was audited. The statutory accounts for this period have been filed with the Registrar of Companies. The auditors' report was unqualified and did not contain a statement under Sections 498 (2) or 498 (3) of the Companies Act 2006.

Β 

The auditor's report was approved by the Directors on 15 June 2023 and is available on the Company's website at www.primorusinvestments.com.

Β 

2. Basis of preparation and accounting

Β 

The financial information has been prepared on the historical cost basis. The Company's business activities, together with the factors likely to affect its future development, performance and position are set out in the Chairman's Statement. This statement also includes a summary of the Company's financial position and its cash flows.

Β 

The financial statements have been prepared in accordance with the Companies Act 2006 and UK-adopted international accounting standards (UK-adopted IAS) and related interpretations. As permitted, this does not include IAS 34 "Interim Financial Reporting". This condensed set of financial statements has been prepared applying the accounting policies that were applied in the preparation of the Company's published financial statements for the year ended 31st December 2022. As these interim financial statements do not include all of the information or disclosures required in the annual financial statements they should be read in conjunction with the Company's 2022 annual financial statements.

Β 

3. Earnings per share

Β 

Earnings per ordinary share has been calculated using the weighted average number of shares in issue during the period. The weighted average number of equity shares in issue was 139,830,968. IAS 33 requires presentation of diluted EPS when a company could be called upon to issue shares that would decrease earnings per share or increase the loss per share.

Β 

Six months

to

Six months

to

Year ended

30 June

2023

30 June

2022

31 December

2022

(Unaudited)

(Unaudited)

(Audited)

restated

(Β£'000)

(Β£'000)

(Β£'000)

Net profit/(loss) attributable to equity holders of

Β Β the company

(512)

(847)

(1,484)

Weighted average number of shares

139,830,968

139,830,968

139,830,968

Weighted average number of diluted shares

139,830,968

139,830,968

139,830,968

Basic (loss)/profit per share (pence)

(0.366)

(0.605)

(1.061)

Diluted (loss)/profit per share (pence)

(0.366)

(0.605)

(1.061)

Β 

Β 

4. Events after the reporting date

Β 

There are no events after the end of the reporting date to disclose that have not already been the subject of an announcement by the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR BSGDIGBBDGXI
Date   Source Headline
2nd Jun 20269:35 amRNSFinal Results
24th Apr 20262:00 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSFurther Investment in Fresho Pty Ltd
10th Feb 20267:00 amRNSBoard role changes
15th Jan 20264:38 pmRNSHolding(s) in Company
9th Jan 20267:00 amRNSTransaction in Own Shares & TR1
8th Jan 20267:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSInvestee Company Update - Virtualstock
23rd Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20252:01 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares & TR-1
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSHolding(s) in Company
24th Jul 20257:48 amRNSTransaction in Own Shares
18th Jul 20254:12 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares & TR-1
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:30 pmRNSAnnouncement by Pri0r1ty Intelligence Group PLC
11th Jul 20258:03 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20251:35 pmRNSResult of AGM
25th Jun 202510:05 amRNSHoldings in Company
25th Jun 20257:00 amRNSInvestee Company Update - Pri0r1ty
13th Jun 20257:00 amRNSNotice of AGM & Proposed Rule 9 Waiver
30th May 20254:25 pmRNSFinal Results
31st Mar 20257:00 amRNSFurther Investment in Interpac Ltd
20th Jan 202511:00 amRNSDirector/PDMR Shareholding
20th Jan 202511:00 amRNSHolding(s) in Company
23rd Dec 20242:10 pmRNSInvestee Company Update – Alteration Earth
5th Nov 20247:00 amRNSSale Of Engage Shareholding
23rd Oct 202412:10 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSHolding(s) in Company
27th Sep 20245:05 pmRNSDirector/PDMR Shareholding
20th Sep 20241:10 pmRNSFurther Investment - Replacement
20th Sep 20247:00 amRNSFurther Investment in Fresho Pty Ltd
5th Sep 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.